Key to long-term value: discipline, execution and consistent communication.

Print pageEmail pageRSS feedsShare page

News releases

The news releases listed below were believed to be accurate in all material respects at the time of original issuance. Please note that we do not intend, and assume no obligation, to update, correct, or otherwise modify any of these press releases for events that occur subsequent to the original release date. We suggest you review the more recent press releases in order to receive the most current information made available by ARIAD.

Keyword Search
2017 | 2016 | 2015 | 2014
01/09/17ARIAD Enters into Definitive Agreement to Be Acquired by Takeda for $5.2 Billion
ARIAD Stockholders to Receive $24.00 per Share in Cash CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 9, 2017-- ARIAD Pharmaceuticals (NASDAQ:ARIA) (“ARIAD”) today announced it has entered into a definitive agreement to be acquired by Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) under which Takeda will acquire all of the outstanding shares in ARIAD for $24.00 per share in cash, or a total enterprise value of approximately $5.2 billion, ... 
Printer Friendly Version
01/09/17Takeda to Acquire ARIAD Pharmaceuticals, Inc.
– Significantly Enhances Takeda’s Global Oncology Portfolio – – Accretive to FY2018 Underlying Core Earnings – – Reinforces Takeda’s Commitment to Developing Medicines for Patients Living with Cancer – Strategic Highlights Highly strategic deal which transforms global oncology portfolio and pipeline by expanding into solid tumors and reinforcing existing strength in hematology ... 
Printer Friendly Version
01/03/17ARIAD to Present at the 35th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 3, 2017-- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA), a rare cancer-focused innovative biotechnology company, today announced that it will present at the 35th Annual J.P. Morgan Healthcare Conference. Paris Panayiotopoulos, president and chief executive officer, will provide an overview of the Company’s business on Monday, January 9, 2017 at 4:30 p.m. (PT). The ARIAD presentation will be webca... 
Printer Friendly Version